Get the Stockscreener App
2.23
5.91%
-0.14
Oramed Pharmaceuticals, Inc Stock (ORMP) Forecast
The Oramed Pharmaceuticals, Inc (ORMP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.1629, representing a +41.83% increase from the current price of $2.23. The highest analyst price target is $3.525, and the lowest is $2.8009.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ORMP Price Target
Average 3.4768
(+55.91% Upside)
Is Oramed Pharmaceuticals, Inc (ORMP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.63 | Neutral |
| STOCH(9,6) | 28.00 | Neutral |
| STOCHRSI(14) | 29.30 | Neutral |
| MACD(12,26) | -0.1516 | Sell |
| ADX(14) | 20.84 | Neutral |
| William %R | -85.07 | Buy |
| CCI(14) | -75.25 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.343
Sell
|
2.3705
Sell
|
| MA20 |
2.5325
Sell
|
2.4924
Sell
|
| MA50 |
2.8486
Sell
|
2.6476
Sell
|
| MA100 |
2.629
Sell
|
2.6677
Sell
|
| MA200 |
2.6517
Sell
|
2.8148
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ORMP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ORMP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.63 indicates that ORMP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28 indicates that ORMP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 29.3 indicates that ORMP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.84 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -75.25 indicates that ORMP is still oversold but not to an extreme extent.
Long-term ORMP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oramed Pharmaceuticals, Inc financial reports and earnings history, Oramed Pharmaceuticals, Inc (ORMP) stock could reach $2.6441 by 2030, $0.5374 by 2040 and $9.2664 by 2050. See the projected annual prices until 2050 of the Oramed Pharmaceuticals, Inc stock below:
- Oramed Pharmaceuticals, Inc (ORMP) is expected to reach an average price of $0.7123 in 2035, with a high prediction of $1.5375 and a low estimate of $0.6723. This indicates an $-68.06% rise from the last recorded price of $2.23.
- Oramed Pharmaceuticals, Inc (ORMP) stock is projected to chart a bullish course in 2040, with an average price target of $0.382, representing an $-82.87% surge from its current level. The forecast ranges from a conservative $0.0802 to a sky-high $0.5374.
- Our analysts predict Oramed Pharmaceuticals, Inc (ORMP) to jump 174.47% by 2045, soaring from $5.3711 to an average price of $6.1207, potentially reaching $8.0159. While $5.3711 is the low estimate, the potential upside is significant.
- Oramed Pharmaceuticals, Inc (ORMP) stock is expected to climb by 2050, reaching an average of $8.1684, a $266.30% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.2664 and $4.3624, respectively, highlighting the market's uncertainty.
Oramed Pharmaceuticals, Inc Stock (ORMP) Year by Year Forecast
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2024
Our forecast for ORMP stock price in 2024 now indicates an average price target of $2.6598 with a high forecast of $3.7108 and a low forecast of $1.6087. The average prediction reflects an increase of +19.27% from the last recorded price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $2.8405 | $2.8009 | $3.525 | +27.37% |
| June, 2024 | $2.2857 | $2.0857 | $2.9639 | +2.50% |
| July, 2024 | $2.5586 | $2.2763 | $3.0281 | +14.73% |
| August, 2024 | $2.9611 | $2.4967 | $3.3399 | +32.78% |
| September, 2024 | $2.6071 | $2.3729 | $3.1817 | +16.91% |
| October, 2024 | $2.4365 | $2.0853 | $2.6359 | +9.26% |
| November, 2024 | $2.3289 | $2.2577 | $2.6551 | +4.44% |
| December, 2024 | $1.9319 | $1.6087 | $2.6501 | -13.37% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2025
Oramed Pharmaceuticals, Inc Stock (ORMP) is expected to reach an average price of $3.5088 in 2025, with a high prediction of $5.345 and a low estimate of $1.6725. This indicates an +57.34% rise from the last recorded price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.7545 | $1.6725 | $5.0838 | +113.20% |
| February, 2025 | $4.1468 | $4.065 | $5.345 | +85.95% |
| March, 2025 | $4.3998 | $3.8174 | $5.1774 | +97.30% |
| April, 2025 | $3.1822 | $3.0622 | $4.5616 | +42.70% |
| May, 2025 | $2.3046 | $1.8134 | $3.1228 | +3.35% |
| June, 2025 | $2.3976 | $2.1552 | $2.6064 | +7.52% |
| July, 2025 | $2.65 | $2.1888 | $2.9394 | +18.84% |
| August, 2025 | $3.4224 | $2.4106 | $3.7118 | +53.47% |
| September, 2025 | $3.2954 | $2.6048 | $3.503 | +47.78% |
| October, 2025 | $3.0679 | $2.8867 | $3.566 | +37.57% |
| November, 2025 | $2.5403 | $2.4003 | $3.2385 | +13.91% |
| December, 2025 | $1.9033 | $1.7233 | $2.6809 | -14.65% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2026
The predicted value for Oramed Pharmaceuticals, Inc (ORMP) in 2026 is set at an average of $12.32. Estimates vary from a peak of $22.92 to a trough of $1.7257, indicating an +452.64% surge from the present price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.8557 | $1.7257 | $2.2851 | -16.79% |
| February, 2026 | $3.7781 | $1.7925 | $4.4781 | +69.42% |
| March, 2026 | $3.8711 | $2.8793 | $4.9087 | +73.59% |
| April, 2026 | $4.8635 | $3.4523 | $5.0335 | +118.10% |
| May, 2026 | $9.9459 | $5.0841 | $11.05 | +346.01% |
| June, 2026 | $9.439 | $6.3171 | $12.07 | +323.27% |
| July, 2026 | $7.7914 | $7.7414 | $10.01 | +249.39% |
| August, 2026 | $10.65 | $7.542 | $11.13 | +377.77% |
| September, 2026 | $13.19 | $10.05 | $14.52 | +491.34% |
| October, 2026 | $11.65 | $10.73 | $13.75 | +422.39% |
| November, 2026 | $17.03 | $10.91 | $22.92 | +663.78% |
| December, 2026 | $18.76 | $13.37 | $20.15 | +741.46% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oramed Pharmaceuticals, Inc (ORMP) is $16.94, with a high forecast of $30.90 and a low forecast of $2.9729. This indicates an +659.50% increase from the last price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.36 | $17.25 | $23.61 | +857.71% |
| February, 2027 | $22.00 | $19.44 | $23.32 | +886.52% |
| March, 2027 | $19.57 | $16.36 | $30.90 | +777.69% |
| April, 2027 | $14.76 | $12.96 | $21.19 | +562.10% |
| May, 2027 | $8.2829 | $8.1279 | $15.17 | +271.43% |
| June, 2027 | $10.70 | $6.8885 | $12.17 | +379.83% |
| July, 2027 | $8.3027 | $8.1927 | $11.19 | +272.32% |
| August, 2027 | $8.0257 | $7.7533 | $9.7839 | +259.90% |
| September, 2027 | $4.5181 | $4.5031 | $8.5563 | +102.61% |
| October, 2027 | $4.2905 | $3.1193 | $5.2937 | +92.40% |
| November, 2027 | $4.2836 | $2.9729 | $4.9236 | +92.09% |
| December, 2027 | $7.366 | $3.6742 | $11.57 | +230.31% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2028
In 2028, Oramed Pharmaceuticals, Inc (ORMP) is projected to reach an average price of $7.1734, with a high projection of $13.13 and a low estimate of $1.214. This indicates an +221.68% rise from the last price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.529 | $6.9172 | $9.849 | +282.47% |
| February, 2028 | $7.9114 | $6.5214 | $8.8196 | +254.77% |
| March, 2028 | $5.4638 | $5.3838 | $8.342 | +145.01% |
| April, 2028 | $6.5062 | $5.1444 | $6.6512 | +191.76% |
| May, 2028 | $7.8492 | $5.4774 | $9.108 | +251.98% |
| June, 2028 | $10.35 | $7.2498 | $10.68 | +364.20% |
| July, 2028 | $1.3446 | $1.214 | $13.13 | -39.70% |
| August, 2028 | $1.5871 | $1.3052 | $1.6565 | -28.83% |
| September, 2028 | $1.3595 | $1.2895 | $1.7185 | -39.04% |
| October, 2028 | $1.6525 | $1.2601 | $1.7075 | -25.90% |
| November, 2028 | $2.2449 | $1.5637 | $2.4739 | +0.67% |
| December, 2028 | $3.4373 | $2.4055 | $4.6661 | +54.14% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2029
The 2029 price forecast for Oramed Pharmaceuticals, Inc Stock (ORMP) is $2.3401 on average, with a high prediction of $3.5779 and a low estimate of $1.1024. This represents an +4.94% increase from the previous price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.8903 | $2.5191 | $3.5779 | +29.61% |
| February, 2029 | $2.8127 | $2.3336 | $3.0109 | +26.13% |
| March, 2029 | $2.6651 | $2.2645 | $3.0433 | +19.51% |
| April, 2029 | $2.0281 | $1.9336 | $3.0463 | -9.05% |
| May, 2029 | $1.4806 | $1.45 | $2.1088 | -33.61% |
| June, 2029 | $1.353 | $1.1024 | $1.663 | -39.33% |
| July, 2029 | $1.676 | $1.3036 | $1.7261 | -24.84% |
| August, 2029 | $1.5212 | $1.49 | $2.04 | -31.78% |
| September, 2029 | $2.006 | $1.5224 | $2.1748 | -10.04% |
| October, 2029 | $1.7021 | $1.3072 | $2.0472 | -23.67% |
| November, 2029 | $1.7869 | $1.6333 | $1.8657 | -19.87% |
| December, 2029 | $2.5729 | $1.7281 | $2.9817 | +15.38% |
Oramed Pharmaceuticals, Inc Stock (ORMP) Price Forecast for 2030
Oramed Pharmaceuticals, Inc Stock (ORMP) is expected to reach an average price of $2.7703 in 2030, with a high forecast of $4.6399 and a low forecast of $0.9007. This signifies an +24.23% surge from the last price of $2.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.914 | $1.8777 | $2.6441 | -14.17% |
| February, 2030 | $1.9125 | $1.3613 | $1.9325 | -14.24% |
| March, 2030 | $1.8373 | $1.6974 | $2.3062 | -17.61% |
| April, 2030 | $2.1074 | $1.776 | $2.6198 | -5.50% |
| May, 2030 | $1.8912 | $1.6558 | $2.1446 | -15.19% |
| June, 2030 | $1.723 | $1.3706 | $1.9218 | -22.73% |
| July, 2030 | $1.7191 | $1.5454 | $1.9428 | -22.91% |
| August, 2030 | $1.2239 | $0.9007 | $1.9403 | -45.12% |
| September, 2030 | $3.9365 | $0.9651 | $4.6399 | +76.53% |
| October, 2030 | $3.7848 | $3.1147 | $4.4747 | +69.72% |
| November, 2030 | $3.6996 | $3.5183 | $4.3071 | +65.90% |
| December, 2030 | $1.6656 | $1.6056 | $3.8632 | -25.31% |
9.92%
4.98%
Cap:
|
Volume (24h):